Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hyperthermia × Temozolomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 42 Neuroblastoma 16 Glioma 15 Brain Neoplasms 13 Astrocytoma 10 Neoplasms 9 Rhabdomyosarcoma 8 Sarcoma, Ewing 7 Recurrence 6 Medulloblastoma 6 Oligodendroglioma 5 Sarcoma 4 Osteosarcoma 4 Melanoma 4 Small Cell Lung Carcinoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive 3 Lymphoma 3 Gliosarcoma 3 Diffuse Intrinsic Pontine Glioma 3 Wilms Tumor 2 Rhabdoid Tumor 2 Pyloric Stenosis, Hypertrophic 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Hepatoblastoma 2 Ganglioneuroblastoma 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2

Interventions

Diathermy 10 Radiotherapy 6 Surgical Procedures, Operative 2 Hyperthermia, Induced 2 Drug Therapy 2 Brachytherapy 2 tislelizumab 1 anlotinib 1 Temozolomide 1 Solutions 1 Radiation 1 Patient Reported Outcome Measures 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Hydrogen Peroxide 1 Folfox protocol 1 Fluorouracil 1 Doxorubicin 1 Dacarbazine 1 Consolidation Chemotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06271421 2024-02-26

ANCHIALE

Poznan University of Medical Sciences

Phase NA Recruiting

Hyperthermia, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡